Skip to main content

Table 4 Study outcome definitions

From: Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Outcome domain Specific measurement Metric and method of aggregation Time point of interest
Health-related quality of life The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym) [28] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Patient experience of care Patient Assessment of Care for Chronic Conditions (PACIC) Effect of time on mean change score between groups Baseline, 6 months, 12 months
Symptom distress Memorial Symptom Assessment Scale (MSAS) [31] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Comorbidity burden The Charleston Comorbidity Index (CCI) supplemented with items from Self-Administered Comorbidity Questionnaire (SCQ) [32] Difference between mean change scores from baseline 12 months
Total leisure-time physical activity Active Australia Survey [33] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Usual vegetable intake and usual fruit intake Two short dietary questions from the National Nutrition Survey [34] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Financial distress 0–10 numerical analogue scale (where 10 is “a great deal” and 0 is “none”) [35] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Employment interference 0–10 numerical analogue scale (where 10 is “a great deal” and 0 is “none”) [36] Effect of time on mean change score between groups Baseline, 6 months, 12 months
Satisfaction of care 0–10 numerical analogue scale (where 10 is “most satisfied” and 0 is “least satisfied”) Difference in mean score between groups 12 months